Allogene Therapeutics, Inc. (ALLO) Current Reports & Earnings Releases
Upcoming
- 2026-11-05 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-22 | 8-K | Shareholder Vote Results, Other Events | SEC |
| 2026-05-28 | 8-K | Officer / Director Changes | SEC |
| 2026-05-13 | 8-K | Material Agreement, Termination of Agreement, Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-15 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-04-13 | 8-K | Other Events | SEC |
| 2026-04-13 | 8-K | Other Events | SEC |
| 2026-03-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-14 | 8-K | Other Events | SEC |
| 2025-08-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-08-01 | 8-K | Other Events | SEC |
| 2025-06-23 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-02-25 | 8-K | Material Agreement | SEC |
| 2025-01-29 | 8-K | Officer / Director Changes | SEC |
| 2024-11-13 | 8-K | Other Events | SEC |
| 2024-11-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-07 | 8-K | Item 5.05, Financial Statements & Exhibits | SEC |
| 2024-08-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-10 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-31 | 8-K | Material Agreement | SEC |
| 2024-05-14 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-05-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-16 | 8-K | Non-Reliance on Financials | SEC |
| 2024-01-31 | 8-K | Material Agreement | SEC |
| 2024-01-05 | 8-K | Material Agreement, Item 2.05, Other Events | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.